436 related articles for article (PubMed ID: 18455252)
1. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
[TBL] [Abstract][Full Text] [Related]
2. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
4. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.
Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M
Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141
[TBL] [Abstract][Full Text] [Related]
5. Fractionated stereotactic radiotherapy boost after post-operative radiotherapy in patients with high-grade gliomas.
Baumert BG; Lutterbach J; Bernays R; Davis JB; Heppner FL
Radiother Oncol; 2003 May; 67(2):183-90. PubMed ID: 12812849
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy.
Combs SE; Steck I; Schulz-Ertner D; Welzel T; Kulozik AE; Behnisch W; Huber PE; Debus J
Radiother Oncol; 2009 Apr; 91(1):60-6. PubMed ID: 19285356
[TBL] [Abstract][Full Text] [Related]
7. High precision conformal radiotherapy employing conservative margins in childhood benign and low-grade brain tumours.
Jalali R; Budrukkar A; Sarin R; Sharma DS
Radiother Oncol; 2005 Jan; 74(1):37-44. PubMed ID: 15683667
[TBL] [Abstract][Full Text] [Related]
8. Accelerated radiotherapy regimen for malignant gliomas using stereotactic concomitant boosts for dose escalation.
Cardinale RM; Schmidt-Ullrich RK; Benedict SH; Zwicker RD; Han DC; Broaddus WC
Radiat Oncol Investig; 1998; 6(4):175-81. PubMed ID: 9727877
[TBL] [Abstract][Full Text] [Related]
9. Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period.
Poortmans PM; Ataman F; Davis JB; Bartelink H; Horiot JC; Pierart M; Collette L; Van Tienhoven G
Radiother Oncol; 2005 Sep; 76(3):278-84. PubMed ID: 15919127
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
[TBL] [Abstract][Full Text] [Related]
11. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.
Cardinale R; Won M; Choucair A; Gillin M; Chakravarti A; Schultz C; Souhami L; Chen A; Pham H; Mehta M
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1422-8. PubMed ID: 16750317
[TBL] [Abstract][Full Text] [Related]
12. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S;
Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
[TBL] [Abstract][Full Text] [Related]
13. High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991.
Ataman F; Poortmans P; Davis JB; Bernier J; Giraud JY; Kouloulias VE; Pierart M; Bolla M
Eur J Cancer; 2004 Nov; 40(16):2411-6. PubMed ID: 15519513
[TBL] [Abstract][Full Text] [Related]
14. Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works.
Poortmans P; Kouloulias V; van Tienhoven G; Collette L; Struikmans H; Venselaar JL; Van den Bogaert W; Davis JB; Lambin P;
Strahlenther Onkol; 2006 Oct; 182(10):576-82. PubMed ID: 17013570
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases.
Lindvall P; Bergström P; Löfroth PO; Henriksson R; Bergenheim AT
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1460-6. PubMed ID: 15817351
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts.
Fahrig A; Ganslandt O; Lambrecht U; Grabenbauer G; Kleinert G; Sauer R; Hamm K
Strahlenther Onkol; 2007 Nov; 183(11):625-30. PubMed ID: 17960338
[TBL] [Abstract][Full Text] [Related]
17. [Role of radiotherapy in recurrent gliomas].
Dhermain F; de Crevoisier R; Parker F; Cioloca C; Kaliski A; Beaudre A; Lefkopoulos D; Armand JP; Haie-Meder C
Bull Cancer; 2004 Nov; 91(11):883-9. PubMed ID: 15582893
[TBL] [Abstract][Full Text] [Related]
18. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
19. Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome.
Combs SE; Schulz-Ertner D; Moschos D; Thilmann C; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):814-9. PubMed ID: 15936565
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results.
Narayana A; Yamada J; Berry S; Shah P; Hunt M; Gutin PH; Leibel SA
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):892-7. PubMed ID: 16458777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
